Lioznov D, Amosova I, Sheetikov SA, Zornikova KV, et al. Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia. PLoS One 2023;18:e0278878.
PMID: 36888640